Authors
Gabriella Newes-Adeyi, Tyler Morrill, Abt Global; Lawrence Reichle, (formerly Abt Global); Sarita Mohanty, Michael Daugherty, Kate Woodworth, Kristina Wielgosz, Romeo Galang, Pete Maniatis, Vera Semenova, Fatimah S. Dawood, Centers for Disease Control and Prevention (CDC); Ashley N. Battarbee, Alan T. Tita, UAB School of Medicine; Michael Varner, The University of Utah Health Sciences Center; Melissa S. Stockwell, Mirella Mourad, Raul A. Silverio Francisco, Columbia University Medical Center
How has SARS-CoV-2 (COVID-19) affected birth outcomes for pregnant persons, and is there a correlation between SARS-CoV-2 infections and preterm live birth? More than three years after the start of the pandemic, researchers are still looking for – and finding – answers. While many studies state that most SARS-CoV-2 infections during pregnancy are mild, others have reported associations between prenatal COVID-19 and adverse pregnancy outcomes. Researchers aim to better inform and advise pregnant persons on the risks of prenatal SARS-CoV-2 infections on newborns, especially as different variants continue to emerge.
During August 2020–October 2021 the Epidemiology of SARS-CoV-2 in Pregnancy and Infancy (ESPI) study enrolled a cohort of pregnant women at less than 28 weeks gestation at three U.S. medical centers in Salt Lake City, UT; New York City, NY; and Birmingham, AL. Participants were followed with systematic surveillance until the end of their pregnancies, self-collecting and returning weekly nasal swab specimens. Additional swab specimens were collected when the particpants experienced any onset of COVID-like symptoms: fever, cough, shortness of breath, etc. Those enrolled also provided blood samples to test for SARS-CoV-2 antibodies as evidence of infection.
Among 954 participants with a live birth, 185 (19%) had evidence of SARS-CoV-2 infection during their pregnancy and 123 (13%) had preterm births. Overall, there was no significant association between preterm birth and SARS-CoV-2 infection during pregnancy. While the infections studied in this analysis were predominantly deemed mild and/or asymptomatic, COVID-19 vaccination for pregnant persons remains important to prevent severe infections that may be associated with additional complications.
Take a deeper dive into this publication to learn more!
Read More
COVID-19 in North America
Housing California Annual Conference 2025
Join Abt Global and other leaders for the Housing California 2025 annual conference in Sacramento.
2025 Innovations and Solutions for Ending Unsheltered Homelessness (NAEH)
Meet the Abt Global team at NAEH’s 2025 Innovations and Solutions for Ending Unsheltered Homelessness conference in Los Angeles.
Human Trafficking Prevalence Estimation Feasibility Study
Abt developed a feasibility study to determine how the U.S. could pilot important data collection to assess national estimates of human trafficking.
Maternal Health in Rural America: Innovative Solutions
States and communities are developing and implementing innovative approaches to reduce the alarmingly high rate of preventable maternal deaths in the rural U.S.